ADALUZIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Apr 2024)
What this means for you
This application is over — abandoned 15 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88809725
- Mark type
- Stylized text
- Filed
- 25 Feb 2020
- Published for opposition
- 12 Jan 2021
- Abandoned
- 15 Apr 2024
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases
Owner
- Basilea Pharmaceutica AG, Basel, CH
- Basilea Pharmaceutica AG, Basel, CH
Prosecution history
- 15 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2023 — SOU EXTENSION 5 GRANTED
- 08 Aug 2023 — SOU EXTENSION 5 FILED
- 08 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2023 — SOU EXTENSION 4 GRANTED
- 27 Feb 2023 — SOU EXTENSION 4 FILED
- 27 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2022 — SOU EXTENSION 3 GRANTED
- 05 Sept 2022 — SOU EXTENSION 3 FILED
- 05 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED